Pharmanutra
Develops and distributes nutritional supplements and medical devices based on research.
PHN | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005274094
- LEI:
- 815600F8217BC7733697
- Country:
- Italy
- Address:
- VIA CAMPODAVELA, 1, 56122 PISA
- Website:
- http://www.pharmanutra.it
- Sector:
- Manufacturing
Description
PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-20 08:50 |
Italian Roadshow 2025 - Paris
|
Italian | 5.4 MB | ||
| 2025-11-14 10:19 |
INTERIM MANAGEMENT REPORT AS AT SEPTEMBER 30, 2025
|
Italian | 1.7 MB | ||
| 2025-11-14 10:17 |
Resoconto intermedio di gestione al 30 settembre 2025
|
Italian | 1.7 MB | ||
| 2025-11-13 09:58 |
Interim Management report as at September 30 2025
|
Italian | 1.8 MB | ||
| 2025-11-13 09:56 |
Resoconto Intermedio di gestione al 30 settembre 2025
|
Italian | 1.7 MB | ||
| 2025-11-13 09:54 |
Avviso deposito Rendiconto Intermedio di gestione al 30 settembre 2025 || Notic…
|
Italian | 225.3 KB | ||
| 2025-11-10 17:51 |
PHARMANUTRA S.P.A.: BOARD OF DIRECTORS APPROVES THE INTERIM MANANGEMENT REPORT …
|
English | 338.9 KB | ||
| 2025-11-10 17:49 |
PHARMANUTRA S.P.A.: CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTE…
|
Italian | 342.0 KB | ||
| 2025-11-04 11:34 |
ALLEGATO 3F - OTTOBRE 2025
|
Italian | 93.2 KB | ||
| 2025-10-20 08:00 |
“SIDERAL® FORTE” PREMIATO COME MIGLIOR PRODOTTO NUTRACEUTICO || “SIDERAL® FORTE…
|
Italian | 278.3 KB | ||
| 2025-10-03 13:13 |
Initiation of share buy-back program
|
English | 243.9 KB | ||
| 2025-10-03 13:12 |
Avvio del programma di acquisti di azioni proprie
|
Italian | 232.8 KB | ||
| 2025-10-01 09:00 |
Eccellenze del Made in Italy | Presentazione
|
English | 5.0 MB | ||
| 2025-09-12 10:35 |
Half Year Financial Report 2025
|
English | 3.3 MB | ||
| 2025-09-12 10:34 |
Relazione finanziaria semestrale 2025
|
Italian | 3.4 MB |
Automate Your Workflow. Get a real-time feed of all Pharmanutra filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharmanutra
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharmanutra via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
